{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "Global Human Recombinant Insulin Market to Exceed at a CAGR of Approximately 7.2% 2023-(BIOCON, BIOTON S.A., ELI LILLY and COMPANY, GAN & LEE PHARMACEUTICALS)",
    "author_name": "Absolute Reports",
    "author_url": "http:\/\/absolutereports.com"
}